In November 2025, the White House announced pricing deals with multiple pharmaceutical manufacturers to lower domestic prices for glucagon-like peptide-1 receptor agonist drugs (GLP-1RAs) including Ozempic, Wegovy, Mounjaro, and Zepbound
Patients should inform their GP and all treating healthcare professionals about Wegovy use during medical consultations, particularly before surgical procedures or when starting new medications
Cost containment pressures drive these decisions
Research has identified specific gene variants associated with GLP-1 drug response, but pharmacogenomic testing for GLP-1 medications is not yet standard clinical practice
Additionally, TMAO has been connected to a higher prevalence of metabolic syndrome and T2D
Increasing pain-free light exposure therefore carries a clinically meaningful purpose that differs from elective tanning